Aldo-Keto Reductase 1B10 (AKR1B10) Restrains Trophoblast Cell Invasion via the ERK Signaling Pathway
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27177728 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Suohao Peng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen 518055, China. Hauptthemen laut MEDLINE: Trophoblasts, MAP Kinase Signaling System, Aldo-Keto Reductase Family 1 member B10, Aldehyde Reductase. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shenzhen Science and Technology Innovation Commission.
Abstract (Originalsprache)
Trophoblast invasion is crucial for the establishment of a functional placenta. Defects in this process can cause adverse pregnancy outcomes, such as miscarriage and preeclampsia. Aldo-keto reductase family 1 member B10 (AKR1B10), a key cytoplasmic oxidoreductase that converts retinoids, retinaldehyde isoprenoids, and lipid peroxidation-derived reactive aldehydes into their corresponding alcohols, regulates cell proliferation, inflammation, and metastasis in cancers. Here, our results demonstrated that AKR1B10 is highly expressed in the ectoplacental cone (EPC) of the mouse placenta. Deficiency of AKR1B10 leads to excessive trophoblast giant cell (TGC) invasion, impaired trophoblast cell differentiation of the junctional zone, and accelerated maternal spiral artery remodeling. Mechanistically, loss of AKR1B10 suppressed extracellular regulated protein kinase (ERK) phosphorylation in both murine placentas and human HTR8/SVneo cells, further promoting HTR8 cell migration and invasion in vitro. Our findings identify AKR1B10 as a critical regulator that restrains trophoblast invasion in the placenta, suggesting it as a new therapeutic target for placental disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen 518055, China.
- Faculty of Pharmaceutical Sciences, Shenzhen University of Advanced Technology, Shenzhen 518107, China.
- Center for Energy Metabolism and Reproduction, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
ORCID-Profile: Suohao Peng, Xiaohua Lei, Chen Huang
Förderung
- National Natural Science Foundation of China
- Shenzhen Science and Technology Innovation Commission
Zitieren
APA
Peng, S., Cai, J., Lei, X., & Huang, C. (2026). Aldo-Keto Reductase 1B10 (AKR1B10) Restrains Trophoblast Cell Invasion via the ERK Signaling Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177728
Vancouver
Peng S, Cai J, Lei X, Huang C. Aldo-Keto Reductase 1B10 (AKR1B10) Restrains Trophoblast Cell Invasion via the ERK Signaling Pathway. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177728
BibTeX
@article{Peng2026,
author = {Peng, Suohao and Cai, Jiaxuan and Lei, Xiaohua and Huang, Chen},
title = {Aldo-Keto Reductase 1B10 (AKR1B10) Restrains Trophoblast Cell Invasion via the ERK Signaling Pathway},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27177728}
}
EUVIMED